Luca Arcaini

66PUBLICATIONS
263CO-AUTHORS
Haematological tumoursPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Medical infection agents (incl. prions)Biomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (66)

|Jun 08, 2026
Occult hepatitis B virus infection status is not associated with impaired efficacy of anti-CD19 CAR-T-cell therapy for lymphoma and shows a distinct immune toxicity profile: Results from the CART-SIE study.

|Jun 08, 2026
Clonal hematopoiesis dynamics influences long-term outcomes of follicular lymphoma: Results from FIL FOLL12 trial.

|May 04, 2026
Dissecting minimal residual disease dynamics to improve outcome prediction in mantle cell lymphoma: Data from the Fondazione Italiana Linfomi (FIL)-MCL0208 clinical trial.

|Mar 29, 2026
Hepatitis C virus and hepatitis B virus in indolent lymphomas: Prospective data from the international observational NF10 study.

Luca Arcaini, Michele Merli, Sara Rattotti

|Oct 24, 2025
Parameters Associated With Renal Recovery and Survival in Myeloma Patients With Acute Renal Failure to Cast Nephropathy.

Heinz Ludwig, Meletios Athanasios Dimopoulos, Evangelos Terpos

|Sep 23, 2025
A SWOT-Consensus for CAR-T in Follicular Lymphoma: Fine Tuning of Patient Journey and Selection.

Monia Marchetti, Paolo Corradini, Luca Arcaini

Pageof 11

Frequent Collaborators

16 joint publications

Michele Merli

8 joint publications

Stefano Luminari

7 joint publications

Marzia Varettoni

7 joint publications

Carlo Visco